X

Health Care

What to look for when Walgreens Boots Alliance reports earnings on Oct. 12

Retail pharmacy chain Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is on the path to a transformation as it looks to…

Infographic: AngioDynamics reports adjusted loss for Q1 2024; sales down 4%

AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the first quarter of 2024…

Ocean Biomedical announces loan commitment of up to $10 million from largest stockholder

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers to develop and commercialize…

Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in…

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues.…

UnitedHealth Group (UNH) looks unfazed by short-term challenges

Healthcare conglomerate UnitedHealth Group (NYSE: UNH) has a good track record of effectively navigating challenges. The company's diversified offerings help…

Earnings Summary: Here’s how CooperCompanies (COO) performed in Q3 2023

Medical device maker CooperCompanies (NYSE: COO) announced financial results for the third quarter of 2023, reporting an increase in revenues.…

Ocean Biomedical (OCEA) announces new patent for anti-fibrosis discovery

Ocean Biomedical, Inc. (NASDAQ: OCEA), a leading biopharma company that works to accelerate the development and commercialization of scientifically compelling…

Medtronic PLC Q1 2024 Earnings Conference Call Insights

Key highlights from Medtronic PLC (MDT) Q1 2024 Earnings Concall Management Update: [00:04:08] MDT is focusing its R&D investments on…

Medtronic (MDT) Q1 2024 Earnings: Key financials and quarterly highlights

Medtronic plc (NYSE: MDT) reported first quarter 2024 earnings results today. Worldwide revenue was $7.7 billion, up 4.5% on a…

MEDS Earnings: Highlights of Trxade Health’s Q2 2023 financial results

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the second quarter…

Agilent Technologies Inc Q3 2023 Earnings Conference Call Insights

Key highlights from Agilent Technologies Inc (A) Q3 2023 Earnings Concall Management Update: [00:04:02] A said it now expects core…

Earnings: All you need to know about Agilent Technologies’ Q3 2023 results

Agilent Technologies (NYSE: A) on Tuesday reported mixed results for the third quarter of 2023 when the medical device company's…

Cardinal Health Inc Q4 2023 Earnings Conference Call Insights

Key highlights from Cardinal Health Inc (CAH) Q4 2023 Earnings Concall Management Update: [00:02:00] CAH delivered record financial performance, including…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries…

Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2023 results

Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted…

Illumina, Inc Q2 2023 Earnings Conference Call Insights

Key highlights from Illumina, Inc (ILMN) Q2 2023 Earnings Concall Management Update: [00:07:42] ILMN now expects to ship more than…

Ocean Biomedical provides update on programs in malaria, fibrosis, and multiple cancers

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday provided an update on its broad range of programs in malaria, fibrosis, and…

Earnings Summary: Highlights of Illumina’s Q2 2023 results

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023. Second-quarter revenue came…

Earnings Summary: Highlights of Organon’s Q2 2023 results

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter…

Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights

Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim…